CONTRAST-INDUCED NEPHROPATHY IN CARDIOLOGY PRACTICE

CONTRAST-INDUCED NEPHROPATHY IN CARDIOLOGY PRACTICE

Contrast-induced nephropathy (CIN) is an important problem in cardiology practice, due to the wide use of contrast-based diagnostic and therapeutic interventions in cardiac patients. Despite the high annual rates of coronary angiography and various coronary interventions, the problem of contrast-ind...

Full description

Bibliographic Details
Main Authors:	O. I. Turenko, A. Yu. Lebedeva, I. G. Gordeev, N. A. Volov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2011-06-01
Series:	Российский кардиологический журнал
Subjects:	contrast-induced nephropathy cardiovascular disease risk factors prevention
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1112

Similar Items

Contrast-induced nephropathy: a review of literature
by: Roya Narenji Sani, et al.
Published: (2015-09-01)

Contrast-induced nephropathy
by: Nazar M. A. Mohammed, et al.
Published: (2013-01-01)

Prevention of contrast induced nephropathy; a cardiology point of view
by: Hashemi Mohammad, et al.
Published: (2015-01-01)

Contrast induced nephropathy: Pathophysiology and prevention
by: Sudarshan Kumar Vijay, et al.
Published: (2013-01-01)

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
by: Peyman Bidram, et al.
Published: (2015-01-01)

Editorial: Contrast-induced nephropathy
by: Sinan Aydoğdu
Published: (2013-02-01)

Risk Factors For Contrast Induced Nephropathy in Surgical Intensive Care Unit Patients
by: Coşkun Araz, et al.
Published: (2012-04-01)

Contrast Induced Nephropathy in ICU settings
by: Raghavendra Vanaki
Published: (2018-01-01)

Contrast-induced nephropathy
by: O Iu Mironova
Published: (2013-06-01)

Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches
by: Prit Kusirisin, et al.
Published: (2020-10-01)

Quercetin, a Promising Clinical Candidate for The Prevention of Contrast-Induced Nephropathy
by: Laura Vicente-Vicente, et al.
Published: (2019-10-01)

Effective long-term hemofiltration in contrast-induced nephropathy
by: E. A. Tabakyan, et al.
Published: (2010-10-01)

Risk of Contrast-Induced Nephropathy after Repeated Contrast Medium Administration
by: Dinesch Violeta, et al.
Published: (2018-09-01)

Contrast-inducible nephropathy in coronarography in patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2009-08-01)

Does Resveratrol Play a Role in Decreasing the Inflammation Associated with Contrast Induced Nephropathy in Rat Model?
by: Yi-Hsin Chen, et al.
Published: (2019-01-01)

Sulodexide Protects Contrast-Induced Nephropathy in Sprague-Dawley Rats
by: Qing Zhao, et al.
Published: (2016-11-01)

The Study of the Efficacy of N-Acetylcysteine for the Prevention of Contrast Induced Nephropathy in Normal Renal Functioning Patients Undergoing Coronary Angiography
by: A. Mohseni, M.D., et al.
Published: (2007-01-01)

Antithrombin III Protects Against Contrast-Induced Nephropathy
by: Zeyuan Lu, et al.
Published: (2017-03-01)

Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention
by: H. Zhang, et al.
Published: (2021-06-01)

Contrast-induced nephropathy: searching for new solutions to prevent its development
by: D.D. Ivanov
Published: (2019-08-01)

Impact of high dose versus low dose atorvastatin on contrast induced nephropathy in diabetic patients with acute coronary syndrome undergoing early percutaneous coronary intervention
by: Haitham Galal, et al.
Published: (2015-12-01)

CONTRAST-INDUCED NEPHROPATHY (CIN): A RAPID OVERVIEW FOR RISK ASSESSMENT AND PREVENTION.
by: Daniele Bissacco
Published: (2017-10-01)

Risk score for contrast induced nephropathy following percutaneous coronary intervention
by: Ghani Amal, et al.
Published: (2009-01-01)

Microalbuminuria predicts contrast-induced nephropathy in patients with acute coronary syndrome
by: Yevgeniy Korolov, et al.
Published: (2021-02-01)

Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy?
by: Orcun Altunoren, et al.
Published: (2015-10-01)

Antithrombin Ⅲ is a Novel Predictor for Contrast Induced Nephropathy After Coronary Angiography
by: Rui Wu, et al.
Published: (2018-02-01)

Contrast-induced nephropathy and biomarkers
by: Polona Likar, et al.
Published: (2013-07-01)

“CONTRAST” STUDY: COMPARİSİON OF NEPHROPROTECTİVE THREE PROTOCOLS: ACETYLCYSTEİNESODİUM BİCARBONATE-THEOPHYLLİNE, TO PREVENT CONTRAST-İNDUCED NEPHROPATHY
by: Ilker Murat Caglar, et al.
Published: (2014-01-01)

Contrast induced nephropathy; recent findings
by: Mardani Saeed, et al.
Published: (2013-04-01)

Efficacy of Oral Nicorandil to Prevent Contrast-Induced Nephropathy in Patients with Chronic Renal Dysfunction Undergoing an Elective Coronary Procedure
by: Zeyuan Fan, et al.
Published: (2019-10-01)

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
by: Ata Firouzi, et al.
Published: (2018-09-01)

The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome
by: Zheng-rong Xu, et al.
Published: (2019-02-01)

Effects of thymoquinone in prevention of experimental contrast-induced nephropathy in rats
by: Ulaş Serkan Topaloğlu, et al.
Published: (2019-12-01)

Original paper<br>Prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary interventions in everyday clinical practice
by: Hanna Bachórzewska-Gajewska, et al.
Published: (2006-12-01)

Limb ischemic preconditioning protects against contrast-induced nephropathy via renalase
by: Feng Wang, et al.
Published: (2016-07-01)

Uric acid and contrast-induced nephropathy: an updated review and meta-regression analysis
by: Francesco Pelliccia, et al.
Published: (2018-12-01)

An Investigation on Hydration with N-acetylcysteine and Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy
by: Rodriguez, Tamara
Published: (2010)

Contrast‐induced nephropathy after cardiac resynchronization therapy implant impairs the recovery of ejection fraction in responders
by: Teresa Strisciuglio, et al.
Published: (2019-12-01)

Contrast-induced nephropathy in patients with acute coronary syndrome: clinical significance, diagnosis, prophylaxis
by: O. V. Demchuk, et al.
Published: (2020-04-01)

PROFILAXIS DE LA NEFROPATÍA INDUCIDA POR CONTRASTE EN PACIENTES DE ALTO RIESGO CON SÍNDROME CORONARIO AGUDO SIN ELEVACIÓN DEL SEGMENTO ST / Prophylaxis of contrast-induced nephropathy in high risk patients with non-ST-segment elevation acute coronary syndrome
by: Pilar Portero Pérez, et al.
Published: (2012-07-01)